Stay updated on HBM4003 Combo with Anti-PD-1: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the HBM4003 Combo with Anti-PD-1: Safety & Efficacy Clinical Trial page.

Latest updates to the HBM4003 Combo with Anti-PD-1: Safety & Efficacy Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.4.3 added and Revision: v3.4.2 removed. This reflects an update to the site's versioning in the page footer.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added to the study record history. The notice regarding government funding and the older Revision: v3.4.1 were removed.SummaryDifference0.9%

- Check41 days agoChange DetectedSite-wide notices about government funding and operating status, along with the revision update to v3.4.1 (replacing v3.4.0), are administrative and do not affect core study data or page function. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check48 days agoChange DetectedUI changes include showing the glossary, green highlights for additions and red highlights for deletions, and revision notes (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check62 days agoChange DetectedRevision: v3.3.4 is added to the record history, replacing the previous v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedThe history shows a new revision (v3.3.3) added and two items removed: HHS Vulnerability Disclosure and Revision: v3.3.2; these are site maintenance/versioning updates rather than trial content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to HBM4003 Combo with Anti-PD-1: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HBM4003 Combo with Anti-PD-1: Safety & Efficacy Clinical Trial page.